Abstract CT173: Molecular residual disease (MRD) interception in locoregionally advanced head and neck squamous cell carcinoma (LA-HNSCC): The MERIDIAN Phase II trial
Year: 2026
Type: conference-abstract
Source: Cancer Research
Authors: Enrique Sanz Garcia, Anna Spreafico, Ali Hosni, John De Almeida, Andrew McPartlin, Lawson Eng, David Goldstein, Andrew Hope, Christopher Yao, Ezra Hahn, John Waldron, Ilan Weinreb, Sakina Hussain, Patricia Inocillas, Lee Krug, Darren Hodgson, Bana Ambasager, Christopher G. Smith, Scott V. Bratman, Lillian L. Siu
Institutions: University Health Network, Princess Margaret Cancer Centre
Language: English
Topic: Head and Neck Cancer Studies
Subfield: Otorhinolaryngology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7154696329